Remote assessment of myotonic dystrophy type 1: A feasibility study
- PMID: 35426155
- PMCID: PMC11629705
- DOI: 10.1002/mus.27559
Remote assessment of myotonic dystrophy type 1: A feasibility study
Abstract
Introduction/aims: Remote study visits (RSVs) are emerging as important tools for clinical research. We tested the feasibility of using RSVs to evaluate patients with myotonic dystrophy type 1 (DM1), including remote quantitative assessment of muscle function, and we assessed correlations of remote assessments with patient-reported function.
Methods: Twenty three subjects with DM1 were consented remotely. Toolkits containing a tablet computer, grip dynamometer, and spirometer were shipped to participants. The tablets were loaded with software for video-conferencing and questionnaires about functional impairment, patient experience with technology, and willingness to participate in future remote studies. Grip strength, forced vital capacity, peak cough flow, timed-up-and-go (TUG), and grip myotonia (hand opening time) were determined during RSVs. We assessed correlations of remote assessments with patient-reported outcomes of muscle function and with CTG repeat size.
Results: All 23 subjects completed RSVs. 95% of participants were able to complete all components of the remote study. All toolkit components were returned upon completion. Grip strength and TUG demonstrated moderate to strong correlations with self-reported inventories of upper and lower extremity impairment, respectively (ρ = 0.7 and ρ = -0.52). A total of 91% of subjects expressed interest in participating in future RSVs.
Discussion: Results of this study support the feasibility of using portable devices and video-conferencing for remote collection of patient-reported outcomes and quantitative assessment of muscle function in DM1.
Keywords: muscle function; myotonic dystrophy; outcome measures; remote assessments; telemedicine.
© 2022 Wiley Periodicals LLC.
Conflict of interest statement
Disclosure of conflict of interest:
None of the authors has any conflict of interest to disclose.
Comment in
-
Remote patient monitoring in neuromuscular disease.Muscle Nerve. 2022 Sep;66(3):233-235. doi: 10.1002/mus.27658. Epub 2022 Jun 28. Muscle Nerve. 2022. PMID: 35674416 No abstract available.
References
-
- Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of a transcript encoding a protein kinase family member. Cell. 1992;69(2):385. - PubMed
-
- Harper P Myotonic Dystrophy. WB Saunders Company; London:. 2001.
-
- Morales F, Couto JM, Higham CF, et al. Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum Mol Genet. 2012;21(16):3558–3567. - PubMed
-
- Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959–969. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources